We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.71B
1-Year Est. Return
65.19%
This Fund
S&P 500
This Quarter
Est. Return
+20.94%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$2.66B
AUM Growth
+$310M
(+13%)
Cap. Flow
-$54M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
18.8%
Holding
435
New
70
Increased
72
Reduced
125
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.2M |
| 2 |
CSX Corp
CSX
|
+$32.5M |
| 3 |
Alibaba
BABA
|
+$31.6M |
| 4 |
Cintas
CTAS
|
+$26.2M |
| 5 |
Intuit
INTU
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$26M |
| 2 |
UnitedHealth
UNH
|
+$26M |
| 3 |
EOG Resources
EOG
|
+$24.5M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$23.8M |
| 5 |
Caterpillar
CAT
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.6% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Industrials | 12.39% |
| 5 | Energy | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSM
126
DELISTED
Versum Materials, Inc.
VSM
| $6.83M | 0.26% |
+135,659
| New | +$5.4M |
|
127
Inspire Medical Systems
INSP
$2.16B
| $6.82M | 0.26% |
120,083
-2,172
| -2% | -$117K |
|
128
Diamondback Energy
FANG
$59.2B
| $6.71M | 0.25% |
66,099
-63,583
| -49% | -$6.51M |
|
|
ATSG
129
DELISTED
Air Transport Services Group
ATSG
| $6.67M | 0.25% |
+289,198
| New | +$6.66M |
|
|
GHDX
130
DELISTED
Genomic Health, Inc.
GHDX
| $6.66M | 0.25% |
95,099
+1,784
| +2% | +$132K |
|
|
ADSW
131
DELISTED
Advanced Disposal Services Inc
ADSW
| $6.61M | 0.25% |
236,141
-110,234
| -32% | -$2.87M |
|
|
HMSY
132
DELISTED
HMS Holdings Corp.
HMSY
| $6.59M | 0.25% |
222,745
+36,720
| +20% | +$1.13M |
|
|
PSXP
133
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $6.58M | 0.25% |
125,699
+24,030
| +24% | +$1.2M |
|
134
STAAR Surgical
STAA
$1.13B
| $6.56M | 0.25% |
191,923
-40,061
| -17% | -$1.42M |
|
135
Tenable Holdings
TENB
$4.2B
| $6.46M | 0.24% |
+204,120
| New | +$5.78M |
|
136
Vericel Corp
VCEL
$2.03B
| $6.38M | 0.24% |
364,585
-37,337
| -9% | -$683K |
|
|
ZNGA
137
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $6.33M | 0.24% |
+1,188,289
| New | +$5.71M |
|
|
AIMC
138
DELISTED
Altra Industrial Motion Corp
AIMC
| $6.24M | 0.24% |
+201,027
| New | +$6.09M |
|
139
Freshpet
FRPT
$3.01B
| $6.22M | 0.23% |
147,145
-2,865
| -2% | -$110K |
|
140
Azenta
AZTA
$1.45B
| $6.2M | 0.23% |
+211,249
| New | +$6.36M |
|
141
CareDx
CDNA
$2.72B
| $6.18M | 0.23% |
196,005
-75,965
| -28% | -$2.21M |
|
142
Red Rock Resorts
RRR
$3.18B
| $6.12M | 0.23% |
+236,814
| New | +$6.12M |
|
143
BP
BP
$121B
| $6.1M | 0.23% |
141,847
+9,759
| +7% | +$400K |
|
|
NVTA
144
DELISTED
Invitae Corporation
NVTA
| $6.08M | 0.23% |
+259,648
| New | +$4.58M |
|
|
FOLD
145
DELISTED
Amicus Therapeutics
FOLD
| $6.01M | 0.23% |
+441,674
| New | +$5.4M |
|
146
Veracyte
VCYT
$3.23B
| $5.96M | 0.22% |
+238,365
| New | +$4.55M |
|
147
Codexis
CDXS
$153M
| $5.9M | 0.22% |
287,454
-5,088
| -2% | -$98.8K |
|
148
Western Midstream Partners
WES
$19.5B
| $5.9M | 0.22% |
+188,111
| New | +$5.97M |
|
149
Kornit Digital
KRNT
$657M
| $5.86M | 0.22% |
+246,351
| New | +$5.24M |
|
|
TPIC
150
DELISTED
TPI Composites
TPIC
| $5.73M | 0.22% |
200,066
-3,687
| -2% | -$109K |
|
Similar funds
MSC
BC
FEG
HCM
OH
BCM
CCI
MCM
Castleark Management's Q1 2019 Portfolio in Review
As of Q1 2019, Castleark Management held 435 positions worth $2.66B, up 13% from $2.35B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Castleark Management's Q1 2019 filing shows 70 new, 72 increased, 125 reduced and 75 closed positions. Its largest new stake was CSX Corp: 1,401,555 shares worth $35M. The largest sale was Eli Lilly, an estimated $26M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Castleark Management's largest Q1 2019 buy was CSX Corp: 1,401,555 shares worth $35M.
- Castleark Management added most to iShares MSCI Emerging Markets ETF in Q1 2019, an estimated $69.2M increase.
- Castleark Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $26M.
- Castleark Management fully exited Align Technology in Q1 2019, selling an estimated $14M.
- Castleark Management's ten largest holdings make up 19% of its $2.66B portfolio in Q1 2019.
- Castleark Management opened 70 new positions and closed 75 in Q1 2019.
- Castleark Management's portfolio value rose 13% quarter-over-quarter to $2.66B.
Based on Castleark Management's 13F filing for Q1 2019, filed 14 May 2019.